{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:38:59Z","timestamp":1761007139397,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.soc.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T23:31:55Z","timestamp":1362785515000},"page":"483-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiation Therapy for Prostate Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Bridget F.","family":"Koontz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Robert","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2013.02.006_bib1","unstructured":"American Cancer Society. Cancer facts and figures 2012. Available at: http:\/\/www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-031941.pdf. Accessed February 28, 2012."},{"issue":"1","key":"10.1016\/j.soc.2013.02.006_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2105\/AJPH.91.1.126","article-title":"Patterns of prostate cancer treatment by clinical stage and age","volume":"91","author":"Meltzer","year":"2001","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib3","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/j.ijrobp.2011.11.024","article-title":"Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007","volume":"82","author":"Dinan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2013.02.006_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0360-3016(01)02812-7","article-title":"Predictive factors of urinary retention following prostate brachytherapy","volume":"53","author":"Bucci","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","article-title":"American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer","volume":"44","author":"Nag","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 5","key":"10.1016\/j.soc.2013.02.006_bib6","first-page":"S20","article-title":"12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"179","author":"Potters","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brachy.2009.01.002","article-title":"Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer","volume":"8","author":"Koontz","year":"2009","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.soc.2013.02.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.05.056","article-title":"Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05)","volume":"81","author":"Lawton","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib9","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/j.ijrobp.2011.11.040","article-title":"Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate","volume":"82","author":"Lawton","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.soc.2013.02.006_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brachy.2011.05.007","article-title":"Rectal toxicity and rectal dosimetry in low-dose-rate (125)I permanent prostate implants: a long-term study in 1006 patients","volume":"11","author":"Keyes","year":"2012","journal-title":"Brachytherapy"},{"issue":"10","key":"10.1016\/j.soc.2013.02.006_bib12","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/1097-0142(20001115)89:10<2085::AID-CNCR8>3.0.CO;2-Q","article-title":"Prostatourethral-rectal fistula after prostate brachytherapy","volume":"89","author":"Theodorescu","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2013.02.006_bib13","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib14","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2008.10.091","article-title":"Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials","volume":"74","author":"Viani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"10.1016\/j.soc.2013.02.006_bib15","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0360-3016(02)04146-9","article-title":"Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial","volume":"55","author":"Yeoh","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2009.12.045","article-title":"Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer","volume":"79","author":"Arcangeli","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2011.06.003","article-title":"Five year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer","volume":"81","author":"Pollack","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.soc.2013.02.006_bib19","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2010.07.170","article-title":"Preliminary report of a randomized dose escalation trial for prostate cancer using hypofraction","volume":"78","author":"Kuban","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.006_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1748-717X-6-3","article-title":"Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes","volume":"6","author":"Freeman","year":"2011","journal-title":"Radiat Oncol"},{"issue":"15","key":"10.1016\/j.soc.2013.02.006_bib21","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/JCO.2010.31.4377","article-title":"Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer","volume":"29","author":"Boike","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.soc.2013.02.006_bib22","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.soc.2013.02.006_bib24","doi-asserted-by":"crossref","first-page":"R363","DOI":"10.1088\/0031-9155\/51\/13\/R21","article-title":"IMRT: a review and preview","volume":"51","author":"Bortfeld","year":"2006","journal-title":"Phys Med Biol"},{"issue":"910","key":"10.1016\/j.soc.2013.02.006_bib25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1259\/bjr\/65676879","article-title":"The physical basis of IMRT and inverse planning","volume":"76","author":"Webb","year":"2003","journal-title":"Br J Radiol"},{"key":"10.1016\/j.soc.2013.02.006_bib26","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.ijrobp.2010.09.017","article-title":"Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study","volume":"81","author":"Middleton","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0360-3016(03)00269-4","article-title":"Prostate localization using transabdominal ultrasound imaging","volume":"56","author":"Trichter","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.urolonc.2008.04.017","article-title":"Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: clinical and cost-utility analyses","volume":"27","author":"Quigley","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.soc.2013.02.006_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijrobp.2010.06.007","article-title":"Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT)","volume":"80","author":"Barney","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2010.05.015","article-title":"Evaluation of the \u2018dose of the day\u2019 for IMRT prostate cancer patients derived from portal dose measurements and cone-beam CT","volume":"96","author":"van Zijtveld","year":"2010","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.soc.2013.02.006_bib31","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1118\/1.3238104","article-title":"IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119","volume":"36","author":"Ezzell","year":"2009","journal-title":"Med Phys"},{"issue":"8","key":"10.1016\/j.soc.2013.02.006_bib32","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1118\/1.1591194","article-title":"Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee","volume":"30","author":"Ezzell","year":"2003","journal-title":"Med Phys"},{"issue":"9","key":"10.1016\/j.soc.2013.02.006_bib33","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1118\/1.3190392","article-title":"Task Group 142 report: quality assurance of medical accelerators","volume":"36","author":"Klein","year":"2009","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2007.03.018","article-title":"Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison","volume":"69","author":"Trofimov","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2013.02.006_bib35","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.25467","article-title":"Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer","volume":"117","author":"Alicikus","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2007.11.066","article-title":"Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes","volume":"71","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.soc.2013.02.006_bib37","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.soc.2013.02.006_bib38","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JCO.2007.13.9881","article-title":"Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610","volume":"26","author":"Roach","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.soc.2013.02.006_bib41","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.soc.2013.02.006_bib42","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions","volume":"25","author":"D'Amico","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.soc.2013.02.006_bib43","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2013.02.006_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2007.12.3752","article-title":"Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31","volume":"27","author":"Efstathiou","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2013.02.006_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1748-717X-7-105","article-title":"Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intraprostate fiducial markers for localized prostate cancer at a single institute in Japan","volume":"7","author":"Takeda","year":"2012","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.soc.2013.02.006_bib46","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1016\/j.ijrobp.2007.07.1383","article-title":"A\u00a0matched pair comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy for prostate cancer: toxicity and outcomes","volume":"69","author":"Morgan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.soc.2013.02.006_bib47","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jama.2011.1333","article-title":"Prediction of erectile function following treatment for prostate cancer","volume":"306","author":"Alemozaffar","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.soc.2013.02.006_bib48","first-page":"230","article-title":"Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors","volume":"5","author":"Mantz","year":"1999","journal-title":"Cancer J Sci Am"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib49","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ijrobp.2009.06.061","article-title":"Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer","volume":"77","author":"Burri","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2013.02.006_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(98)00492-0","article-title":"Salvage brachytherapy for localized prostate cancer after radiotherapy failure","volume":"53","author":"Grado","year":"1999","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.soc.2013.02.006_bib51","first-page":"1407","article-title":"Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and\/or penetration through the capsule","volume":"138","author":"Anscher","year":"1987","journal-title":"J\u00a0Urol"},{"issue":"15","key":"10.1016\/j.soc.2013.02.006_bib52","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.soc.2013.02.006_bib53","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","article-title":"Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy","volume":"299","author":"Trock","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.soc.2013.02.006_bib54","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ijrobp.2010.07.107","article-title":"10-year results of adjuvant radiotherapy after radical prostatectomy in pT3N0 prostate cancer (EORTC 22911)","volume":"78","author":"Bolla","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.soc.2013.02.006_bib55","first-page":"956","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"18","key":"10.1016\/j.soc.2013.02.006_bib56","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.soc.2013.02.006_bib57","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1200\/JCO.2006.10.4067","article-title":"Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911","volume":"25","author":"Van der Kwast","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2003.10.006","article-title":"Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment","volume":"59","author":"van der Linden","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.soc.2013.02.006_bib59","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jnci\/dji139","article-title":"Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases","volume":"97","author":"Hartsell","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","article-title":"8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party","volume":"52","year":"1999","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.soc.2013.02.006_bib61","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.ijrobp.2011.12.028","article-title":"Split-course, high-dose palliative pelvic radiotherapy for locally progressive hormone-refractory prostate cancer","volume":"83","author":"Gogna","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib62","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0360-3016(94)90389-1","article-title":"Late effect of multiple daily fraction palliation schedule for advanced pelvic malignancies (RTOG 8502)","volume":"29","author":"Spanos","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib63","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0360-3016(93)90309-J","article-title":"Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer","volume":"25","author":"Porter","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib64","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.urology.2004.01.034","article-title":"Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer","volume":"63","author":"Sartor","year":"2004","journal-title":"Urology"},{"issue":"5S","key":"10.1016\/j.soc.2013.02.006_bib65","article-title":"Overall survival benefit and safety profile of radium-223 chloride, a first-in-class alpha pharmaceutical: results from a phase III randomized trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) with bone metastases","volume":"30","author":"Parker","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"25","key":"10.1016\/j.soc.2013.02.006_bib66","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1200\/JCO.2006.06.3875","article-title":"Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial","volume":"24","author":"Wallace","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.soc.2013.02.006_bib67","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/cncr.10919","article-title":"An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up","volume":"95","author":"Vicini","year":"2002","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2013.02.006_bib68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.soc.2013.02.006_bib69","first-page":"289","article-title":"Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial","volume":"299","author":"D'Amico","year":"2008","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.soc.2013.02.006_bib70","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma\u2014long-term results of phase III RTOG 85-31","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"10.1016\/j.soc.2013.02.006_bib71","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1200\/JCO.2007.14.9021","article-title":"Ten-year follow-up of Radiation Therapy Oncology Group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer","volume":"26","author":"Horwitz","year":"2008","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320713000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320713000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:58:01Z","timestamp":1760961481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320713000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1055320713000185"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2013.02.006","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2013.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}